Michael Dassa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael Dassa has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Alexis Jacquier
Radiology Department, La Timone Hospital, Assistance Publique Des Hopitaux de Marseille, Marseille 05, France
3 shared publicationsArnaud Maurin
Radiology Department, La Timone Hospital, Assistance Publique Des Hopitaux de Marseille, Marseille 05, France
3 shared publicationsAxel Bartoli
Radiology Department, La Timone Hospital, Assistance Publique Des Hopitaux de Marseille, Marseille 05, France
3 shared publicationsBaptiste Marchi
Radiology Department, La Timone Hospital, Assistance Publique Des Hopitaux de Marseille, Marseille 05, France
3 shared publicationsDidier Raoult
IHU-Méditerranée Infection, Marseille, France
3 shared publicationsJulie Finance
IHU-Méditerranée Infection, Marseille, France
3 shared publications
Latest Publications
- 16 March 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (6) , 108734
Percutaneous Image-Guided Screw Fixation Combined with Cementoplasty for Radiation-Induced Pelvic Insufficiency Fractures: Feasibility, Safety, and Early Outcomes in a Multicenter Retrospective Study
- 16 March 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (6) , 108734
Percutaneous Image-Guided Screw Fixation Combined with Cementoplasty for Radiation-Induced Pelvic Insufficiency Fractures: Feasibility, Safety, and Early Outcomes in a Multicenter Retrospective Study
- Open Access
- 8 November 2024
- Published by Springer Nature in Insights into Imaging
- Vol. 15 (1) , 1
Author Correction: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19
- 8 November 2024
- Published by Springer Nature in Insights into Imaging
- Vol. 15 (1) , 1
Open AccessAuthor Correction: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19
- Open Access
- 16 February 2021
- Published by Springer Nature in Insights into Imaging
- Vol. 12 (1) , 1
Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19
An amendment to this paper has been published and can be accessed via the original article.
- 16 February 2021
- Published by Springer Nature in Insights into Imaging
- Vol. 12 (1) , 1
Open AccessCorrection to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19
An amendment to this paper has been published and can be accessed via the original article.
- 25 January 2021
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 44 (6) , 903-910
Efficacy of Tract Embolization After Percutaneous Pulmonary Radiofrequency Ablation
Purpose To evaluate the efficacy of tract embolization technique using gelatin sponge slurry with iodinated contrast medium (GSSI) to reduce the incidence of pneumothorax and chest tube placement after computed tomography-guided lung radiofrequency ablation (RFA). Materials and Methods In this single-institute retrospective study, we examined all patients with metastatic cancer treated from January 2016 to December 2019 by interventional radiologists with computed tomography-guided lung RFA. Since 2017 in our institution, we have applied a tract embolization technique using GSSI for all RFA. Patients were included into those who underwent lung RFA performed either with GSSI (Group A) or without GSSI (Group B). Univariate and multivariate analyses were performed between the two groups to identify risk factors for pneumothorax and chest tube placement, including patient demographics and lesion characteristics. Results This study included 116 patients (54 men, 62 women; mean age, 65 ± 11 years) who underwent RFA. Group A comprised 71 patients and Group B comprised 45 patients. Patients who underwent tract embolization had a significantly lower incidence of pneumothorax (Group A, 34% vs. Group B, 62%; p < 0.001) and chest tube insertion (Group A, 10% vs. Group B, 29%; p < 0.01). No embolic complications occurred. The hospitalization stay was significantly shorter in patients who underwent tract embolization (mean, 1.04 ± 0.2 days; p = 0.02). Conclusion Tract embolization after percutaneous lung RFA significantly reduced the rate of post-RFA pneumothorax and chest tube placement and was safer than the standard lung RFA technique.
- 25 January 2021
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 44 (6) , 903-910
Efficacy of Tract Embolization After Percutaneous Pulmonary Radiofrequency Ablation
Purpose To evaluate the efficacy of tract embolization technique using gelatin sponge slurry with iodinated contrast medium (GSSI) to reduce the incidence of pneumothorax and chest tube placement after computed tomography-guided lung radiofrequency ablation (RFA). Materials and Methods In this single-institute retrospective study, we examined all patients with metastatic cancer treated from January 2016 to December 2019 by interventional radiologists with computed tomography-guided lung RFA. Since 2017 in our institution, we have applied a tract embolization technique using GSSI for all RFA. Patients were included into those who underwent lung RFA performed either with GSSI (Group A) or without GSSI (Group B). Univariate and multivariate analyses were performed between the two groups to identify risk factors for pneumothorax and chest tube placement, including patient demographics and lesion characteristics. Results This study included 116 patients (54 men, 62 women; mean age, 65 ± 11 years) who underwent RFA. Group A comprised 71 patients and Group B comprised 45 patients. Patients who underwent tract embolization had a significantly lower incidence of pneumothorax (Group A, 34% vs. Group B, 62%; p < 0.001) and chest tube insertion (Group A, 10% vs. Group B, 29%; p < 0.01). No embolic complications occurred. The hospitalization stay was significantly shorter in patients who underwent tract embolization (mean, 1.04 ± 0.2 days; p = 0.02). Conclusion Tract embolization after percutaneous lung RFA significantly reduced the rate of post-RFA pneumothorax and chest tube placement and was safer than the standard lung RFA technique.
- 1 December 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 297 (3) , 721-729
Image-guided Percutaneous Fixation with Internal Cemented Screws of Impending Femoral Neck Pathologic Fractures in Patients with Metastatic Cancer: Safety, Efficacy, and Durability
This study confirms the efficacy and safety of percutaneous fixation with internal cemented screws performed by interventional radiologists to stabilize impending femoral neck pathologic fractures. Background Prophylactic image-guided procedures performed by interventional radiologists for impending pathologic fractures are becoming more pertinent, as patients with metastatic cancer have exte...
- 1 December 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 297 (3) , 721-729
Image-guided Percutaneous Fixation with Internal Cemented Screws of Impending Femoral Neck Pathologic Fractures in Patients with Metastatic Cancer: Safety, Efficacy, and Durability
This study confirms the efficacy and safety of percutaneous fixation with internal cemented screws performed by interventional radiologists to stabilize impending femoral neck pathologic fractures. Background Prophylactic image-guided procedures performed by interventional radiologists for impending pathologic fractures are becoming more pertinent, as patients with metastatic cancer have exte...
- Open Access
- 17 November 2020
- Published by Springer Nature in Insights into Imaging
- Vol. 11 (1) , 1-10
Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19
Background: Low-dose chest CT (LDCT) showed high sensitivity and ability to quantify lung involvement of COVID-19 pneumopathy. The aim of this study was to describe the prevalence and risk factors for lung involvement in 247 patients with a visual score and assess the prevalence of incidental findings. Methods: For 12 days in March 2020, 250 patients with RT-PCR positive tests and who underwent LDCT were retrospectively included. Clinical and imaging findings were recorded. The extent of lung involvement was quantified using a score ranging from 0 to 40. A logistic regression model was used to explore factors associated with a score ≥ 10. Results: A total of 247 patients were analyzed; 138 (54%) showed lung involvement. The mean score was 4.5 ± 6.5, and the mean score for patients with lung involvement was 8.1 ± 6.8 [1–31]. The mean age was 43 ± 15 years, with 121 males (48%) and 17 asymptomatic patients (7%). Multivariate analysis showed that age > 54 years (odds ratio 4.4[2.0–9.6] p < 0.001) and diabetes (4.7[1.0–22.1] p = 0.049) were risk factors for a score ≥ 10. Multivariate analysis including symptoms showed that only age > 54 years (4.1[1.7–10.0] p = 0.002) was a risk factor for a score ≥ 10. Rhinitis (0.3[0.1–0.7] p = 0.005) and anosmia (0.3[0.1–0.9] p = 0.043) were protective against lung involvement. Incidental imaging findings were found in 19% of patients, with a need for follow-up in 0.6%. Conclusion: The prevalence of lung involvement was 54% in a predominantly paucisymptomatic population. Age ≥ 55 years and diabetes were risk factors for significant parenchymal lung involvement. Rhinitis and anosmia were protective against LDCT abnormalities.
- 17 November 2020
- Published by Springer Nature in Insights into Imaging
- Vol. 11 (1) , 1-10
Open AccessPrevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19
Background: Low-dose chest CT (LDCT) showed high sensitivity and ability to quantify lung involvement of COVID-19 pneumopathy. The aim of this study was to describe the prevalence and risk factors for lung involvement in 247 patients with a visual score and assess the prevalence of incidental findings. Methods: For 12 days in March 2020, 250 patients with RT-PCR positive tests and who underwent LDCT were retrospectively included. Clinical and imaging findings were recorded. The extent of lung involvement was quantified using a score ranging from 0 to 40. A logistic regression model was used to explore factors associated with a score ≥ 10. Results: A total of 247 patients were analyzed; 138 (54%) showed lung involvement. The mean score was 4.5 ± 6.5, and the mean score for patients with lung involvement was 8.1 ± 6.8 [1–31]. The mean age was 43 ± 15 years, with 121 males (48%) and 17 asymptomatic patients (7%). Multivariate analysis showed that age > 54 years (odds ratio 4.4[2.0–9.6] p < 0.001) and diabetes (4.7[1.0–22.1] p = 0.049) were risk factors for a score ≥ 10. Multivariate analysis including symptoms showed that only age > 54 years (4.1[1.7–10.0] p = 0.002) was a risk factor for a score ≥ 10. Rhinitis (0.3[0.1–0.7] p = 0.005) and anosmia (0.3[0.1–0.9] p = 0.043) were protective against lung involvement. Incidental imaging findings were found in 19% of patients, with a need for follow-up in 0.6%. Conclusion: The prevalence of lung involvement was 54% in a predominantly paucisymptomatic population. Age ≥ 55 years and diabetes were risk factors for significant parenchymal lung involvement. Rhinitis and anosmia were protective against LDCT abnormalities.